These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34119171)

  • 41. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
    Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
    J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles.
    Sousa F; Cruz A; Fonte P; Pinto IM; Neves-Petersen MT; Sarmento B
    Sci Rep; 2017 Jun; 7(1):3736. PubMed ID: 28623267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
    Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.
    Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y
    Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy.
    Zhang XP; Sun JG; Yao J; Shan K; Liu BH; Yao MD; Ge HM; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2018 Nov; 107():1056-1063. PubMed ID: 30257317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
    Sokol MB; Nikolskaya ED; Yabbarov NG; Zenin VA; Faustova MR; Belov AV; Zhunina OA; Mollaev MD; Zabolotsky AI; Tereshchenko OG; Severin ES
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1150-1158. PubMed ID: 30281905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice.
    Paul P; Sengupta S; Mukherjee B; Shaw TK; Gaonkar RH; Debnath MC
    Nanomedicine (Lond); 2018 Mar; 13(5):501-520. PubMed ID: 29383985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.
    Shi Y; Xue J; Jia L; Du Q; Niu J; Zhang D
    Colloids Surf B Biointerfaces; 2018 Jan; 161():67-72. PubMed ID: 29040836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
    Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
    AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties.
    Miele D; Rossi S; Sandri G; Vigani B; Sorrenti M; Giunchedi P; Ferrari F; Bonferoni MC
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30445668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.